Chien-Yu Cheng to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications Chien-Yu Cheng has written about Reverse Transcriptase Inhibitors.
Connection Strength
0.293
-
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up. PLoS One. 2017; 12(6):e0179870.
Score: 0.148
-
Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan. PLoS One. 2017; 12(2):e0171596.
Score: 0.145